{
  "main_header": {
    "sid": 1157879,
    "name": "Eterna Therapeutics, Inc.",
    "stock_name": "Eterna Therapeutics, Inc.",
    "full_name": "Eterna Therapeutics, Inc.",
    "name_url": "stocks-analysis/eterna-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.31",
    "chg": 0.11,
    "chgp": "9.17%",
    "dir": 1,
    "prev_price": "1.20",
    "mcapval": "9.51",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US1140822099",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "218.47 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eterna-therapeutics-inc-1157879-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eterna Therapeutics Hits 52-Week Low Amid Significant Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eterna-therapeutics-hits-52-week-low-amid-significant-market-decline-3519672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/EternaTherapeut_priceRelatedfactors_3519672.png",
        "date": "2025-09-16 11:35:09",
        "description": "Eterna Therapeutics, Inc. has reached a 52-week low of $11.40, reflecting a 50.21% decline over the past year. With a market cap of around $10 million, the company faces financial challenges, including a negative price-to-earnings ratio, no dividend yield, and a low return on equity of -380.29%."
      }
    ],
    "total": 5,
    "sid": "1157879",
    "stock_news_url": "https://www.marketsmojo.com/news/eterna-therapeutics-inc-1157879"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Eterna Therapeutics Hits 52-Week Low Amid Significant Market Decline

2025-09-16 11:35:09

Eterna Therapeutics, Inc. has reached a 52-week low of $11.40, reflecting a 50.21% decline over the past year. With a market cap of around $10 million, the company faces financial challenges, including a negative price-to-earnings ratio, no dividend yield, and a low return on equity of -380.29%.

Read More

View All News